NTHI · Neonc Technologies Holdings, Inc.
$4.69
+0.09 (+1.85%)
At close · Aug 28
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“While the proceeds from the PIPE Financing and the Series A Convertible Preferred Stock financing have provided additional liquidity during the six months ended June 30, 2026, management does not believe these proceeds, together with the Company’s other available resources, are sufficient to fund operations for at least twelve months from the date of issuance of these financial statements, and substantial doubt about the Company’s ability to continue as a going concern therefore remains, as discussed above.”View the 10-Q filed Aug 10, 2026
Market Cap
$121.64M
Shares
25.94M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.69
Open$4.57
Day$4.51–4.75
52W close$3.21–12.09
Avg vol 30d208K
Short int598K · 2.3% float · 1.7d
Short vol56%
Last earningsAug 12, 2026
DataMar 2025–Aug 2026
Filing10-Q · Aug 10
Up next
Next earnings call
Nov 6, 2026
Est · unconfirmed
· in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 10, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Poor
Quant / Vol
Very High
Market backdrop
VIX 14.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−30%
below
Price vs 50-day avg
+14%
above
RSI (14)
57
neutral
MACD trend
Positive
52-week position
17%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+34%
trailing
6-month return
−52%
trailing
YTD return
−43%
this year
Relative strength
−65%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $7 — 200d above 50d
Institutional flow
Distributing
-26% holders QoQ · +2 funds added
Insider flow
Accumulating
Net +$318.4K over 90 days · 0% sells
Short interest
Falling
2.30% of float · ▼ -3.3% MoM · 1.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
20 holders — mid 1-yr range
Squeeze score
43
elevated · 0–100
Fundamentals
Revenue growth
−52%
Y/Y
EPS growth
−364%
Y/Y
Quant / Vol
risk profile
Volatility
111%
annualized · 1-yr
Max drawdown
−73%
past year
ATR
10.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−30%
Bearish
Price vs 50-day avg
+14%
Bullish
RSI (14)
57
Neutral
MACD trend
Positive
Bullish
52-week position
17%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $4 › 200d $7 — 200d above 50d
Institutional flow
Distributing
-26% holders QoQ · +2 funds added
Insider flow
Accumulating
Net +$318.4K over 90 days · 0% sells
Short interest
Falling
2.30% of float · ▼ -3.3% MoM · 1.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
20 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $3
Now $5 · 17%
Range high $12
vs 200-day avg -30%
vs 50-day avg +14%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Non-cash stock-based compensation expense non-GAAP | -$5,651,913 | Three Months Ended June 30, 2026 | — |
| Non-GAAP total operating expenses excluding stock-based compensation non-GAAP | $8,417,974 | Three Months Ended June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP GAAP total operating expenses $14,069,887
-$5,651,913 Less: Non-cash stock-based compensation expense
= Non-GAAP total operating expenses excluding stock-based compensation $8,417,974
|
|||
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NTHI
this stock
Neonc Technologies Holdings, Inc.
|
$121.64M | -43.3% | -51.8% | — | 2.3% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$137.30B | +19.5% | +46.2% | 31.6 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.27B | +2.9% | +20.8% | 19.6 | 2.3% |
|
ARGX
Argenx SE
|
$63.63B | +21.7% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$59.23B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NTHI | +0.3% | +34.4% | -51.8% | +34.4% | -43.3% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | -0.2% | +31.4% | -65.2% | +31.4% | -56.1% |
Key facts
CIK
1979414
CUSIP
64051A101
13F (30d)
18 filings
18 filers
Visit website
Investor relations